Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
- PMID: 1685032
- DOI: 10.1002/syn.890090404
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
Abstract
The present document is the second of three parts in a review that focuses on recent data from clinical and animal research concerning the biochemical bases of depressive disorders, diagnosis, and treatment. Various receptor/transmitter theories of depressive disorders are discussed in this section. Specifically, data supporting noradrenergic, serotonergic, cholinergic, dopaminergic, GABAergic, and peptidergic theories, as well as interactions between noradrenergic and serotonergic, or cholinergic and catecholaminergic systems are presented. Problems with the data and future directions for research are also discussed. A previous publication, Part I of this review, dealt with the classification of depressive disorders and research techniques for studying the biochemical mechanisms of these disorders. A future publication, Part III of this review, discusses treatments for depression and some of the controversies in this field.
Similar articles
-
Clinical and biochemical aspects of depressive disorders: I. Introduction, classification, and research techniques.Synapse. 1991 Jul;8(3):185-211. doi: 10.1002/syn.890080306. Synapse. 1991. PMID: 1948669 Review.
-
Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies.Synapse. 1992 Feb;10(2):141-68. doi: 10.1002/syn.890100209. Synapse. 1992. PMID: 1585257 Review.
-
Neurobiological mechanisms in generalized anxiety disorder.J Clin Psychiatry. 2001;62 Suppl 11:22-7; discussion 28. J Clin Psychiatry. 2001. PMID: 11414547 Review.
-
Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.Psychopharmacology (Berl). 2002 Oct;163(3-4):434-58. doi: 10.1007/s00213-002-1139-6. Epub 2002 Aug 6. Psychopharmacology (Berl). 2002. PMID: 12373445 Review.
-
[Mechanisms of falling asleep. (Possibility of drug therapy in sleep disorders--participation of monoaminergic and gabaergic systems in the sleep-waking cycle)].Arzneimittelforschung. 1981;Suppl 27:15-7. Arzneimittelforschung. 1981. PMID: 6118157 German. No abstract available.
Cited by
-
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.Psychopharmacology (Berl). 2003 Aug;168(4):397-409. doi: 10.1007/s00213-003-1389-y. Epub 2003 Apr 30. Psychopharmacology (Berl). 2003. PMID: 12721776
-
Behaviour of a genetic mouse model of depression in the learned helplessness paradigm.Psychopharmacology (Berl). 2011 Jun;215(3):595-605. doi: 10.1007/s00213-011-2218-3. Epub 2011 Feb 22. Psychopharmacology (Berl). 2011. PMID: 21340472
-
Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine.Naunyn Schmiedebergs Arch Pharmacol. 1995 Aug;352(2):141-8. doi: 10.1007/BF00176767. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7477436
-
Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: reversal by naloxone.Psychopharmacology (Berl). 1994 Apr;114(3):433-40. doi: 10.1007/BF02249333. Psychopharmacology (Berl). 1994. PMID: 7855201
-
Effects of milnacipran in animal models of anxiety and memory.Neurochem Res. 2006 Apr;31(4):571-7. doi: 10.1007/s11064-006-9050-x. Epub 2006 May 9. Neurochem Res. 2006. PMID: 16758367
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources